 Ceftazidime monotherapy teicoplanin initial empiric treatment presumed bacteremia febrile granulocytopenic patients prospective randomized study febrile granulocytopenic patients initial therapy ceftazidime teicoplanin onset fever patients obvious infectious focus assessable episodes initial bacteremias patients ceftazidime patients combination bacteremias gram-positive bacteria groups difference terms final response patients ceftazidime patients combination morbidity comparable treatment groups duration fever total antibiotic therapy similar groups Initial therapy patients ceftazidime infection patients combination Persistent fever main reason treatment patient gram-positive infection Subsequent infective events patients ceftazidime patients combination Lung patients new infections combination group Allergic skin reactions frequent group teicoplanin simple reliable safe treatment patients presumed gram-positive infections useful patient population treatment infective complications adverse events